|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.890 USD | +2.59% |
|
-3.61% | +16.90% |
| 03-06 | Relay Therapeutics, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 03:10 PM | |
| 02-26 | Relay Therapeutics Q4 Loss Narrows, Revenue Rises; Cash Runway Into 2029 | MT |
| Capitalization | 1.77B 1.52B 1.38B 1.32B 2.41B 162B 2.52B 16.26B 6.52B 77.9B 6.63B 6.49B 279B | P/E ratio 2026 * |
-6.58x | P/E ratio 2027 * | -7.12x |
|---|---|---|---|---|---|
| Enterprise value | 1.54B 1.33B 1.2B 1.15B 2.09B 141B 2.19B 14.14B 5.67B 67.73B 5.77B 5.65B 242B | EV / Sales 2026 * |
289x | EV / Sales 2027 * | 87.4x |
| Free-Float |
97.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Relay Therapeutics, Inc.
| 1 day | +2.59% | ||
| 1 week | -3.61% | ||
| Current month | -3.61% | ||
| 1 month | +10.87% | ||
| 3 months | +28.78% | ||
| 6 months | +140.05% | ||
| Current year | +16.90% |
| 1 week | 9.06 |  | 10.68 |
| 1 month | 8.35 | | 11.43 |
| Current year | 7.01 | | 11.43 |
| 1 year | 1.78 | | 11.43 |
| 3 years | 1.78 | | 19.23 |
| 5 years | 1.78 | | 40.78 |
| 10 years | 1.78 | | 64.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjiv Patel
CEO | Chief Executive Officer | 52 | 28/02/2017 |
Thomas Catinazzo
DFI | Director of Finance/CFO | 49 | 31/03/2018 |
Jim Watters
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Douglas Ingram
BRD | Director/Board Member | 63 | 31/05/2019 |
Linda Hill
BRD | Director/Board Member | 69 | 08/10/2018 |
Alexis Borisy
CHM | Chairman | 54 | 03/05/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.59% | -3.61% | +184.20% | -41.69% | 1.77B | |
| -2.02% | -5.97% | -11.64% | -10.60% | 45.49B | |
| +2.79% | -5.01% | +17.18% | +26.18% | 33.41B | |
| +0.47% | -10.90% | +17.49% | +52.87% | 31.32B | |
| -2.25% | -2.42% | -5.92% | -20.53% | 29.29B | |
| -1.24% | -3.55% | +150.89% | +294.55% | 19.5B | |
| +1.39% | +3.06% | +58.83% | +111.91% | 14.77B | |
| +0.26% | +4.17% | +44.47% | +134.63% | 13.36B | |
| -1.64% | -5.25% | +24.86% | +3.99% | 13.22B | |
| -1.49% | -8.76% | +115.30% | +104.25% | 12.23B | |
| Average | -0.11% | -3.68% | +59.57% | +65.56% | 21.44B | |
| Weighted average by Cap. | -0.40% | -4.58% | +32.14% | +55.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.31M 4.58M 4.13M 3.96M 7.23M 488M 7.57M 48.85M 19.57M 234M 19.93M 19.5M 837M | 19.19M 16.54M 14.94M 14.33M 26.13M 1.76B 27.35M 177M 70.73M 846M 72.02M 70.48M 3.02B |
| Net income | -268M -231M -209M -200M -365M -24.66B -382M -2.47B -989M -11.83B -1.01B -986M -42.3B | -255M -220M -199M -191M -348M -23.47B -364M -2.35B -941M -11.26B -959M -938M -40.26B |
| Net Debt | -231M -199M -180M -172M -314M -21.2B -329M -2.12B -850M -10.17B -866M -847M -36.36B | -90.02M -77.61M -70.06M -67.22M -123M -8.27B -128M -828M -332M -3.97B -338M -331M -14.19B |
Employees
192
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 9.890 $ | +2.59% | 1,420,119 |
| 05/03/26 | 9.640 $ | -5.02% | 1,977,221 |
| 04/03/26 | 10.15 $ | +3.05% | 2,664,280 |
| 03/03/26 | 9.850 $ | +0.61% | 2,696,094 |
| 02/03/26 | 9.790 $ | -4.58% | 2,858,505 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
9.890USD
Average target price
15.64USD
Spread / Average Target
+58.10%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RLAY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition